Rockefeller Capital Management’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-611
Closed -$235K 3277
2022
Q4
$235K Sell
611
-946
-61% -$267K ﹤0.01% 1588
2022
Q3
$372K Sell
1,557
-116
-7% -$31.1K ﹤0.01% 1382
2022
Q2
$372K Buy
1,673
+205
+14% +$88.2K ﹤0.01% 1375
2022
Q1
$999K Sell
1,468
-6
-0.4% -$3.61K ﹤0.01% 1054
2021
Q4
$1.02M Buy
1,474
+237
+19% +$175K ﹤0.01% 1045
2021
Q3
$917K Buy
1,237
+169
+16% +$115K ﹤0.01% 1034
2021
Q2
$800K Buy
1,068
+204
+24% +$156K ﹤0.01% 1007
2021
Q1
$704K Sell
864
-16
-2% -$12.3K ﹤0.01% 913
2020
Q4
$750K Sell
880
-26
-3% -$20K 0.01% 775
2020
Q3
$679K Buy
+906
New +$744K 0.01% 697

Other funds holding OM

Rockefeller Capital Management's OM Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Outset Medical (OM) in Q1 2023, closing a stake of 611 shares — an estimated $235K sold.

Rockefeller Capital Management first reported a position in OM in Q3 2020 and held it in 10 quarters. The position peaked at $1.02M in Q4 2021. 162 funds tracked by Wall St. Rank hold OM as of Q1 2023.

  • Rockefeller Capital Management reported no remaining Outset Medical position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 611 Outset Medical shares in Q1 2023, an estimated $235K.
  • Rockefeller Capital Management first reported a position in Outset Medical in Q3 2020 and held it in 10 quarters.
  • Rockefeller Capital Management's Outset Medical position peaked at $1.02M in Q4 2021.
  • 162 funds tracked by Wall St. Rank held Outset Medical as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.